UB Paderborn / Katalog / Suche / in CDI

1 – 17 von 17

Sortiert nach

Combination of 'omics' data to investigate the mechanism(s) of hydrazine-induced hepatotoxicity in Rats and to identify potential biomarkers

Biomarkers, 2004-03, Vol.9 (2), p.116-138

2004

Volltextzugriff (PDF)

Albumin binding of insulins acylated with fatty acids: characterization of the ligand-protein interaction and correlation between binding affinity and timing of the insulin effect in vivo

Biochemical journal, 1995-12, Vol.312 ( Pt 3) (3), p.725-731

1995

Volltextzugriff (PDF)

Characterization of high molecular weight plasma protein complexes induced by clotting factor rFXIII‐treatment in the cynomolgus monkey

Journal of thrombosis and haemostasis, 2007-10, Vol.5 (10), p.2070-2078

2007

Volltextzugriff (PDF)

Preclinical toxicity biomarkers for combination treatment with clotting factors rFXIII and rFVIIa

Biomarkers, 2007-07, Vol.12 (4), p.424-444

2007

Volltextzugriff (PDF)

Levormeloxifene: safety, pharmacodynamics and pharmacokinetics in healthy postmenopausal women following single and multiple doses of a new selective oestrogen receptor modulator

British journal of clinical pharmacology, 2002-03, Vol.53 (3), p.284-295

2002

Volltextzugriff (PDF)

Levormeloxifene: Safety & Pharmacokinetics in Young Versus Elderly Postmenopausal Women

Clinical pharmacology and therapeutics, 1999-02, Vol.65 (2), p.192-192

1999

Volltextzugriff (PDF)

Pharmacokinetics and allometric scaling of levormeloxifene, a selective oestrogen receptor modulator

Biopharmaceutics & drug disposition, 2003-04, Vol.24 (3), p.121-129

2003

Volltextzugriff (PDF)

Albumin Binding and Time Action of Acylated Insulins in Various Species

Journal of pharmaceutical sciences, 1996-03, Vol.85 (3), p.304-308

1996

Volltextzugriff (PDF)

Metabolism, disposition, excretion, and pharmacokinetics of levormeloxifene, a selective estrogen receptor modulator, in the rat

Drug metabolism and disposition, 2000-05, Vol.28 (5), p.503

2000

Volltextzugriff (PDF)

Assay for levormeloxifene, a selective estrogen receptor modulator, in human and monkey plasma employing high-performance liquid chromatography and solid-phase extraction

Journal of chromatography. B, Biomedical sciences and applications, 1999-06, Vol.729 (1), p.315-322

1999

Volltextzugriff (PDF)

Pharmacokinetics of levormeloxifene in young versus elderly postmenopausal women

Clinical therapeutics, 2001, Vol.23 (1), p.62-71

2001

Volltextzugriff (PDF)

The Cobalt(lll)–Insulin Hexamer is a Prolonged‐Acting Insulin Prodrug

Journal of pharmaceutical sciences, 1995-10, Vol.84 (10), p.1164-1168

1995

Volltextzugriff (PDF)

Non-linear mixed effects modeling of sparse concentration data from rats: application to a glycogen phosphorylase inhibitor

European journal of drug metabolism and pharmacokinetics, 2002-07, Vol.27 (3), p.203-212

2002

Volltextzugriff (PDF)

Driving gradual endogenous c-myc overexpression by flow-sorting: intracellular signaling and tumor cell phenotype correlate with oncogene expression

Archives of toxicology, 2009-12, Vol.83 (12), p.1061-1074

2009

Volltextzugriff (PDF)

MCF-7 human mammary adenocarcinoma cells exhibit augmented responses to human insulin on a collagen IV surface

Journal of applied toxicology, 2009-08, Vol.29 (6), p.470-477

2009

Volltextzugriff (PDF)

Surveys for potential biocontrol agents for moth plant in New Zealand and Argentina

New Zealand plant protection, 2006-01, Vol.59, p.18-22

Waipara, N. W

2006

Volltextzugriff (PDF)

Challenger Jerusalem artichoke

Canadian journal of plant science, 1985-01, Vol.65 (3), p.803-805

1985

Volltextzugriff (PDF)

1 – 17 von 17

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(16)
Mit Volltextzugriff
(16)

Publikationsform

Artikel
(17)

Sprache

Englisch
(17)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Combination of 'omics' data to investigate the mechanism(s) of hydrazine-induced hepatotoxicity in Rats and to identify potential biomarkers

Albumin binding of insulins acylated with fatty acids: characterization of the ligand-protein interaction and correlation between binding affinity and timing of the insulin effect in vivo

Characterization of high molecular weight plasma protein complexes induced by clotting factor rFXIII‐treatment in the cynomolgus monkey

Preclinical toxicity biomarkers for combination treatment with clotting factors rFXIII and rFVIIa

Levormeloxifene: safety, pharmacodynamics and pharmacokinetics in healthy postmenopausal women following single and multiple doses of a new selective oestrogen receptor modulator

Levormeloxifene: Safety & Pharmacokinetics in Young Versus Elderly Postmenopausal Women

Pharmacokinetics and allometric scaling of levormeloxifene, a selective oestrogen receptor modulator

Albumin Binding and Time Action of Acylated Insulins in Various Species

Metabolism, disposition, excretion, and pharmacokinetics of levormeloxifene, a selective estrogen receptor modulator, in the rat

Assay for levormeloxifene, a selective estrogen receptor modulator, in human and monkey plasma employing high-performance liquid chromatography and solid-phase extraction

Pharmacokinetics of levormeloxifene in young versus elderly postmenopausal women

The Cobalt(lll)–Insulin Hexamer is a Prolonged‐Acting Insulin Prodrug

Non-linear mixed effects modeling of sparse concentration data from rats: application to a glycogen phosphorylase inhibitor

Driving gradual endogenous c-myc overexpression by flow-sorting: intracellular signaling and tumor cell phenotype correlate with oncogene expression

MCF-7 human mammary adenocarcinoma cells exhibit augmented responses to human insulin on a collagen IV surface

Surveys for potential biocontrol agents for moth plant in New Zealand and Argentina

Challenger Jerusalem artichoke

Suchergebnisse filtern